Results 61 to 70 of about 17,585,100 (417)

FoxO1 signaling in B cell malignancies and its therapeutic targeting

open access: yesFEBS Letters, EarlyView.
FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac   +3 more
wiley   +1 more source

The role of European Union on immigration. An anthropological approach to the treaties that have been carried out in Europe in order to manage diversity

open access: yesREGION, 2019
Migrations are a global phenomenon that has prevailed throughout history. In the last decades there is a need to control every person who enters and leaves the borders of a country.
Carmen Clara Bravo Torres
doaj   +1 more source

The THEMA tool to support heritage-based development strategies for marginal areas

open access: yesREGION, 2022
The ongoing forced reflection on the leading urbanization models' crisis has led to greater attention to marginal areas. In Italy, the scientific and media debate has focused on inner areas that, since 2014, have represented the target of an innovative ...
Marco Rossitti, Francesca Torrieri
doaj   +1 more source

Search for Majorana Neutrinos Near the Inverted Mass Hierarchy Region with KamLAND-Zen. [PDF]

open access: yesPhysical Review Letters, 2016
We present an improved search for neutrinoless double-beta (0νββ) decay of ^{136}Xe in the KamLAND-Zen experiment. Owing to purification of the xenon-loaded liquid scintillator, we achieved a significant reduction of the ^{110m}Ag contaminant identified ...
A. Gando   +40 more
semanticscholar   +1 more source

State of Our Estuaries 2013 [PDF]

open access: yes, 2013
Every three years the Piscataqua Region Estuaries Partnership (PREP) produces this condition and environmental trends report in an effort to provide communities and citizens with an informed and comprehensive evaluation of what is being observed in our ...
Piscataqua Region Estuaries Partnership
core   +1 more source

The immunological interface: dendritic cells as key regulators in metabolic dysfunction‐associated steatotic liver disease

open access: yesFEBS Letters, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects nearly one‐third of the global population and poses a significant risk of progression to cirrhosis or liver cancer. Here, we discuss the roles of hepatic dendritic cell subtypes in MASLD, highlighting their distinct contributions to disease initiation and progression, and their ...
Camilla Klaimi   +3 more
wiley   +1 more source

Why you should publish open access

open access: yesREGION, 2015
This editorial discusses the difference between creative common and commercial licenses from the point of view of the author of an article.
Gunther Maier
doaj   +1 more source

Territorial marginality: causes, methods and policies.

open access: yesREGION, 2023
What are the different factors that make a territory marginal? Are contextual features related to spatial, socioeconomic, institutional, or cultural elements differently influencing marginality in different countries?
Bruna Vendemmia   +2 more
doaj   +1 more source

Object Region Mining with Adversarial Erasing: A Simple Classification to Semantic Segmentation Approach [PDF]

open access: yesComputer Vision and Pattern Recognition, 2017
We investigate a principle way to progressively mine discriminative object regions using classification networks to address the weakly-supervised semantic segmentation problems.
Yunchao Wei   +5 more
semanticscholar   +1 more source

Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia

open access: yesFEBS Letters, EarlyView.
This Review explores how the phosphoinositide 3‐kinase and protein kinase B pathway shapes B cell development and drives chronic lymphocytic leukemia, a common blood cancer. It examines how signaling levels affect disease progression, addresses treatment challenges, and introduces novel experimental strategies to improve therapies and patient outcomes.
Maike Buchner
wiley   +1 more source

Home - About - Disclaimer - Privacy